An Empirical Study on the Impact of Information Disclosure Quality of Listed Companies on the Resignation of Independent Directors
DOI:
https://doi.org/10.54691/bcpbm.v30i.2426Keywords:
Independent Directors; Quality of information disclosure; Reputation.Abstract
In recent years, there have been frequent scandals of financial information falsification in listed companies, independent directors have been held jointly and severally liable for large sums of money, and the recent wave of resignations of independent directors has led to extensive consideration by scholars. This paper is based on a comparison of the resignations of Kangmei Pharmaceutical and a comparative analysis of the resignations of independent directors of two companies, Dalian Shengya and Shougang Hotel. It is concluded that the correlation between disclosure quality ratings and independent director resignations is negative. It can therefore be inferred that the level of disclosure practiced by listed corporations is a decisive factor in the resignation of independent directors, which leads to further recommendations on the system of independent directors.
Downloads
References
Guo Fuqing. Paradoxes, defects and solutions of independent directors in China: Reflections on the resignation of independent directors triggered by the "Kangmei Pharmaceuticals case" [J]. Academic Forum, 2022, 45(01): 61-73.
Jia Li, Shi Chunling. Financial restatement and independent directors' voluntary resignation--and the credibility of the reasons for resignation [J/OL]. Finance and Accounting Monthly: 1-9 [2022-05-11].
Research Group on Governance of Listed Companies, Tai Bing. Research on the legal responsibility of independent directors in information disclosure of listed companies [J/OL]. Securities Market Herald: 1-9 [2022-05-19].
Zhang Dunli, Wang Qinwen. "Covering up" or "hoodwinking"--The dilemma of independent directors' accountability from listed companies' financial fraud [J]. Journal of Finance and Accounting, 2022(04): 16-22.
Zhang Cheng. Can independent directors "get it right" after the Kangmei case [J]. Procuratorial wind and cloud, 2021(24): 36-37.
Chu Jian, Fang Junxiong. External regulatory environment and individual remuneration incentives of independent directors: a study based on the spillover effect of regulatory penalties [J]. Accounting and Economic Research, 2021, 35(06): 37-57.6.002.
Yu Xingxi. A correct view of the Kangmei Pharmaceutical case and the independent director system [J]. Board of Directors, 2021(11): 72-79.
Yao Yan. The current situation and countermeasures of the independent director system of listed companies in China [J]. China Management Informatization, 2021, 24(20): 32-33.
Zhao Li-Nan. 19 companies make announcements in 8 days. A-share resignation tide of independent directors? [N]. Daily Economic News, 2021-11-22(011) [1] Qiao Pengcheng, Zhou Jinwa. Research on the tide of independent directors' resignation and the improvement of corporate governance [J]. China collective economy, 2017(33): 88-89.
Liu Junhai. Rethinking and reconstructing the system of independent directors of listed companies: legal reflections on the huge joint and several liability of sole directors in the case of Kangmei Pharmaceutical [J]. Journal of Law, 2022, 43(03): 1-27.
Yuan Kang. Liability of independent directors and institutional reconstruction: from the case of Kangmei Pharmaceuticals [J]. Jingchu Jurisprudence, 2022(02): 132-147.
Downloads
Published
Issue
Section
How to Cite
